Just reported
From Zimmer Biomet's results release of 2026년 11월 4일; its quarterly report has since been filed.
Actual
US$2.06B
+3.1% y/y
-5.2% q/q
Guided
—
No guide given
Actual
US$1.00
-14% y/y
-2.9% q/q
Guided
—
No guide given
Actual
US$307.6M
-12% y/y
-5.7% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Zimmer Biomet is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
매출 비중은 six months ended June 30, 2026 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
Knee replacement implants
Artificial parts that replace all or part of a damaged knee, including components used in later repair or replacement procedures.
Hip replacement systems
Artificial parts that replace the ball and socket of the hip; some are fixed with bone cement and others are designed to attach directly to bone.
Sports medicine, extremities and trauma devices
Devices used to repair soft-tissue injuries, stabilize broken bones, and treat conditions in the foot, ankle, shoulder, elbow and wrist.
ROSA Robot
A surgical robot that helps surgeons position implants during certain knee, hip and shoulder procedures.
ZBEdge
A group of robotic and digital technologies that gathers information before, during and after surgery to help inform patient care.
Bone cement
Cement and related mixing and delivery products used to attach some orthopedic implants to bone.
Zimmer Biomet makes artificial knees and hips, as well as devices used to repair injuries to bones, joints, and surrounding soft tissue. Surgeons use its ROSA robot to help position implants during some operations. Hospitals and surgery centers buy products directly or through distributors and dealers; many products are kept on consignment for use when a procedure is scheduled.
Zimmer Biomet Holdings, Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.
Zimmer Biomet sells knee and hip replacement implants and other devices for bone and joint surgery to hospitals, surgery centers, and surgeons.
Grade B
주가 아래 띠는 각 날짜의 등급으로, 그 시점까지 공개된 자료만으로 산출했습니다.
Zimmer Biomet Holdings, Inc.의 등급 이력 41개 분기 중 2개를 표시하고 있습니다. 나머지 39개는 2016년 11월까지 거슬러 올라갑니다.